TipRanks
NeoPharm Co., Ltd. (KR:092730)
:092730
South Korea Market
092730
NeoPharm Co., Ltd.
RESEARCH TOOLSreports

NeoPharm Co., Ltd. (092730) Ratios

― Followers

NeoPharm Co., Ltd. Ratios

KR:092730's free cash flow for Q1 2026 was ₩0.65. For the 2026 fiscal year, KR:092730's free cash flow was decreased by ₩ and operating cash flow was ₩0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.75 8.40 10.12 7.63 9.99
Quick Ratio
 5.23 7.65 9.28 7.06 9.33
Cash Ratio
 0.99 1.28 1.21 0.67 0.83
Solvency Ratio
 0.96 1.24 1.68 1.42 1.42
Operating Cash Flow Ratio
 0.77 1.35 1.23 1.32 1.38
Short-Term Operating Cash Flow Coverage
 22.95 26.60 37.23 1.32K 977.11
Net Current Asset Value
₩ 151.36B₩ 151.54B₩ 137.49B₩ 117.07B₩ 118.13B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.17 1.13 1.09 1.11 1.09
Debt Service Coverage Ratio
 23.43 24.78 48.41 637.26 680.02
Interest Coverage Ratio
 629.27 729.87 604.53 1.19K 2.42K
Debt to Market Cap
 <0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 108.57 124.96 42.85 139.04 53.83
Net Debt to EBITDA
 -0.96 -0.78 -0.53 -0.35 -0.42
Profitability Margins
Gross Profit Margin
49.91%64.09%62.20%67.33%68.66%
EBIT Margin
21.14%21.77%25.42%30.27%27.44%
EBITDA Margin
22.93%24.11%28.02%31.94%29.34%
Operating Profit Margin
21.71%21.77%20.71%26.06%25.21%
Pretax Profit Margin
25.12%24.41%25.38%30.25%27.43%
Net Profit Margin
21.43%21.05%19.38%23.90%20.02%
Continuous Operations Profit Margin
21.43%21.05%19.38%23.90%20.02%
Net Income Per EBT
85.28%86.24%76.35%79.03%73.00%
EBT Per EBIT
115.73%112.12%122.53%116.07%108.79%
Return on Assets (ROA)
13.01%12.63%11.99%13.08%10.96%
Return on Equity (ROE)
15.48%14.24%13.04%14.51%11.97%
Return on Capital Employed (ROCE)
15.37%14.44%13.90%15.83%15.08%
Return on Invested Capital (ROIC)
13.03%12.39%10.56%12.46%10.97%
Return on Tangible Assets
13.11%12.73%12.11%13.25%11.09%
Earnings Yield
16.35%15.26%12.44%23.62%22.62%
Efficiency Ratios
Receivables Turnover
 8.58 9.19 9.33 9.13 11.09
Payables Turnover
 5.72 6.20 8.94 4.93 7.20
Inventory Turnover
 2.17 3.05 3.55 3.11 3.05
Fixed Asset Turnover
 4.62 4.38 4.00 3.32 9.10
Asset Turnover
 0.61 0.60 0.62 0.55 0.55
Working Capital Turnover Ratio
 0.89 0.90 0.93 0.83 0.75
Cash Conversion Cycle
 146.77 100.62 101.17 83.24 102.00
Days of Sales Outstanding
 42.56 39.73 39.14 39.97 32.90
Days of Inventory Outstanding
 167.98 119.77 102.84 117.31 119.81
Days of Payables Outstanding
 63.76 58.88 40.81 74.05 50.71
Operating Cycle
 210.54 159.50 141.98 157.29 152.71
Cash Flow Ratios
Operating Cash Flow Per Share
 1.58K 1.82K 1.19K 2.98K 2.32K
Free Cash Flow Per Share
 1.50K 1.74K 994.41 311.55 2.22K
CapEx Per Share
 77.21 75.74 196.74 2.67K 103.11
Free Cash Flow to Operating Cash Flow
 0.95 0.96 0.83 0.10 0.96
Dividend Paid and CapEx Coverage Ratio
 2.33 2.69 2.08 0.88 2.89
Capital Expenditure Coverage Ratio
 20.44 23.98 6.05 1.12 22.52
Operating Cash Flow Coverage Ratio
 14.95 14.83 29.60 21.84 44.06
Operating Cash Flow to Sales Ratio
 0.18 0.21 0.16 0.24 0.21
Free Cash Flow Yield
13.10%14.93%8.39%2.48%23.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.12 6.55 8.04 4.23 4.42
Price-to-Sales (P/S) Ratio
 1.31 1.38 1.56 1.01 0.89
Price-to-Book (P/B) Ratio
 0.93 0.93 1.05 0.61 0.53
Price-to-Free Cash Flow (P/FCF) Ratio
 7.64 6.70 11.92 40.36 4.34
Price-to-Operating Cash Flow Ratio
 7.26 6.42 9.95 4.22 4.15
Price-to-Earnings Growth (PEG) Ratio
 -2.82 0.32 -11.43 0.12 -1.14
Price-to-Fair Value
 0.93 0.93 1.05 0.61 0.53
Enterprise Value Multiple
 4.75 4.94 5.03 2.82 2.60
Enterprise Value
 148.98B 157.46B 167.74B 87.46B 64.81B
EV to EBITDA
 4.75 4.94 5.03 2.82 2.60
EV to Sales
 1.09 1.19 1.41 0.90 0.76
EV to Free Cash Flow
 6.35 5.78 10.78 35.92 3.73
EV to Operating Cash Flow
 6.04 5.54 9.00 3.76 3.57
Tangible Book Value Per Share
 12.17K 12.38K 11.18K 20.19K 17.95K
Shareholders’ Equity Per Share
 12.28K 12.49K 11.31K 20.48K 18.18K
Tax and Other Ratios
Effective Tax Rate
 0.15 0.14 0.24 0.21 0.27
Revenue Per Share
 8.75K 8.45K 7.61K 12.43K 10.87K
Net Income Per Share
 1.87K 1.78K 1.47K 2.97K 2.18K
Tax Burden
 0.85 0.86 0.76 0.79 0.73
Interest Burden
 1.19 1.12 1.00 1.00 1.00
Research & Development to Revenue
 0.02 0.03 0.03 0.03 0.03
SG&A to Revenue
 0.29 0.40 0.28 0.26 0.27
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.84 1.02 0.81 1.00 1.07
Currency in KRW